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Ovine lentivirus (OvLV) isolates 85/34 (OvLV 34) and 84/28 (OvLV 28) were initially characterized as phenotypically distinct
“rapid/high” and “slow/low” strains based on replication kinetics, syncytiogenesis, and cell lysis in vitro. In the present study,
sera from OvLV-34- or OvLV-28-infected monozygotic twin lambs defined these virus strains as distinct neutralization
serotypes. We also show that immune recognition of at least one OvLV neutralization epitope is influenced by genetic
differences between lambs. Additional studies determined the neutralization phenotype of virus isolates from alveolar
macrophages of OvLV-34- or OvLV-28-infected lambs, evaluated the role of neutralizing antibodies in selection and
persistence of antigenic variants, and related the severity of OvLV-induced lymphoid interstitial pneumonia (LIP) to the
evolution of neutralization variants. These studies demonstrate that (i) macrophage-associated OvLV neutralization variants
can arise in the presence or the absence of neutralizing antibodies directed to inoculum viruses, (ii) OvLV variants persist
in macrophages in the presence of serum neutralizing antibodies, and (iii) the emergence of OvLV variants is apparently
unrelated to the severity of LIP. © 1999 Academic Press
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tINTRODUCTION
Ovine lentiviruses (OvLV) are monocyte/macrophage
ropic lentiviruses of sheep commonly referred to as
aedi/visna or ovine progressive pneumonia viruses.
vLV have been associated with a spectrum of nonsup-
urative inflammatory lesions, principally lymphoid inter-
titial pneumonia (LIP) and encephalomyelitis (Narayan
t al., 1993). OvLV isolates are phenotypically distin-
uishable in vitro based on replication kinetics, syncy-
iogenesis, and cell lysis in goat synovial membrane
GSM) cultures (Querat et al., 1984). Using these criteria,
vLV isolates OvLV 34 and OvLV 28 were classified as
ytic “rapid/high” (R/H) and persistent “slow/low” (S/L)
trains (Lairmore et al., 1987; Woodward et al., 1995).
valuation of the development of LIP in three sets of
rtificially produced identical twin lambs inoculated with
ither R/H OvLV 85/34 or S/L OvLV 84/28, designated
vLV 34 and OvLV 28, respectively, demonstrated that
he severity of OvLV-induced lung lesions is host deter-
ined and unrelated to the in vitro phenotype of OvLV
trains (de la Concha-Bermejillo et al., 1995).
OvLV persists indefinitely in bone marrow stem cells
nd bone marrow-derived peripheral monocytes and
endritic cells with active replication in tissue macro-
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382hages. It is likely that nonproductive infection of mac-
ophage precursors is the principal mechanism of per-
istence of monocyte/macrophage tropic lentiviruses
Narayan et al., 1993). However, evolution of neutraliza-
ion escape mutants may contribute to virus persisence
s well as relatively high virus loads associated with
evelopment of lesions and clinical disease (Burns and
esrosiers, 1994). The present study addressed this
uestion using macrophage-derived virus isolates from
onozygotic twin lambs infected with OvLV 34 or OvLV
8 (de la Concha-Bermejillo et al., 1995; Woodward et al.,
995). Virus isolates were defined as antigenic variants
f OvLV 34 or OvLV 28 by differential serum neutraliza-
ion. However, our results raise the question of whether
esistance to neutralizing antibodies is the sole mecha-
ism of selection and persistence of macrophage-asso-
iated antigenic variants and also do not support the
ypothesis that persistent replication of antigenic vari-
nts contributes to disease pathogenesis.
RESULTS
eutralizing antibodies induced by OvLV 34
nd OvLV 28
Lambs A34, B34, and C34 inoculated with R/H OvLV 34
nd lambs A28 (twin of A34), B28 (twin of B34), and C28
twin of C34) inoculated with S/L OvLV 28 (Table 1) were
ecropsied at 20 weeks postinoculation (PI) for evalua-
ion of LIP (de la Concha-Bermejillo et al., 1995) and virus
eisolation from bronchoalveolar lavage macrophages
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383OVINE LENTIVIRUS PHENOTYPESWoodward et al., 1995). To determine the relative capac-
ty of R/H OvLV 34 and S/L OvLV 28 to induce homolo-
ous and cross-reactive neutralizing antibodies, these
irus strains were evaluated for neutralization by 20-
eek sera taken at necropsy. These results are shown in
able 2.
Terminal sera from lambs A34, B34, and C34 neutral-
zed .99% of 104.11 TCID50 of the OvLV 34 inoculum and
id not neutralize 103.32 or 101.56 TICD50 of heterologous
vLV 28. In contrast, only one of three OvLV-28-infected
ambs had serum neutralizing antibodies against the
vLV 28 inoculum. Serum from this lamb (C28) neutral-
TABLE 1
Nomenclature for Twin Sets, Viral Inocula, and Virus Isolates
Recovered from Infected Lambs
Twin setsa Animal No.a Inoculuma
Recovered
virus isolateb
win set A
A34 89-30 OvLV 34 A34.1
A28 89-29 OvLV 28 A28.1
win set B
B34 90-07 OvLV 34 B34.1
B28 90-08 OvLV 28 B28.1
win set C
C34 89-36 OvLV 34 —
C28 89-37 OvLV 28 —
a Twin sets A–C employed animals produced, inoculated, and num-
ered previously (de la Concha-Bermejillo et al., 1995).
b OvLV isolates recovered from alveolar macrophages at necropsy 20
eeks postinoculation were previously characterized (Woodward et al.,
995).
T
Neutralization of OvLV 34
Sera
OvLV 34a
Expt. 1
Control 4.11 6 1.17 3.
Twin set A (31)b
A34 1.40* (99.8)
A28 3.08 2.
Twin set B (11)
B34 2.02* (99.2)
B28 3.32 2.
Twin set C (11)
C34 0.94* (99.9)
C28 1.89* (99.4)
Note. Serum neutralization of OvLV 34 and OvLV 28 was evaluated b
eparate titrations with serum from four mock-infected lambs. (*) P
eutralization assays using homologous sera are in bold type. Numbe
a Virus OvLV 34, inoculum for lambs A34, B34, and C34; virus OvLV
b Numbers in parentheses indicate severity of LIP at 20 weeks PI: 31, severezed 99.6% of 103.32 TCID50 of OvLV 28 virus, whereas sera
rom the other two lambs (A28 and B28) did not detect-
bly neutralize 103.32 or 101.56 TICD50 of OvLV 28 virus.
erum from lamb C28 also neutralized 99.4% of 104.11
CID50 of heterologous OvLV 34. Sera from OvLV-28-
nfected lambs A28 and B28 did not detectably neutralize
04.11 TCID50 of heterologous OvLV 34 but did neutralize
7.6 and 91.9% of OvLV 34 virus assayed at a lower
nfectivity titer of 103.10 TCID50.
The data in Table 2 indicate that OvLV 34 and OvLV 28
nduced neutralizing antibodies with markedly different
pecificities and also suggested differences in the ge-
etic potential of lambs to recognize at least one neu-
ralization epitope of OvLV 28. OvLV 34 induced only
ype-specific neutralizing antibodies in the three lambs
nfected with this virus strain. However, the specificity of
eutralizing antibody responses to OvLV 28 was less
istinct. This virus strain induced homologous neutraliz-
ng antibodies only in lamb C28, indicating that recogni-
ion of at least one OvLV 28 neutralization epitope re-
uired a specific immunogenetic background not repre-
ented in lambs A28 and B28. All three OvLV-28-infected
ambs also had serum antibodies that neutralized heter-
logous OvLV 34. However, lack of neutralization of OvLV
8 by sera of OvLV 34 virus-infected lambs ruled out the
resence of OvLV-34-specific neutralization epitopes ex-
ressed by OvLV 28. Therefore, we attributed neutraliza-
ion of heterologous OvLV 34 by sera from OvLV 28
irus-infected lambs to acquisition of the OvLV-34-spe-
ific epitope through antigenic variation of OvLV 28 in
ivo.
To obtain independent evidence for acquisition of the
by 20-Week Lamb Sera
us titer (Log10TCID50/0.1 ml)
OvLV 28
2 Expt. 1 Expt. 2
.63 3.32 6 0.45 1.56 6 0.33
3.08 1.49
.6) 3.01 1.44
3.01 1.28
.9) 3.45 1.65
2.97 1.24
0.92* (99.6)
titer reduction. Control virus titers (mean 6 3 SD) were determined by
neutralization (.3 SD reduction of control virus titer). Results of
arentheses indicate the percentage of reduction of virus titer.
culum for lambs A28, B28, and C28.ABLE 2
and 28
Vir
Expt.
10 6 0
45* (77
01* (91
y virus
ositive
rs in p
28, inolesions; 11, insignificant lesions (de la Concha-Bermejillo et al., 1995).
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384 CHEEVERS ET AL.vLV 34 neutralization epitope by antigenic variation of
vLV 28, we evaluated neutralization of homologous
vLV 28 and heterologous OvLV 34 viruses by sera from
amb C28 drawn at various intervals prior to 20 weeks PI.
esults demonstrated that 8-week serum neutralized
03.07 TCID50 of heterologous OvLV 34, whereas neutral-
zation of 103.10 TCID50 of homologous OvLV 28 was not
etected until 12 weeks PI (Table 3). In addition, neutral-
zing antibody titers of 20-week serum from lamb C28
gainst approximately 103 TCID50 of OvLV 28 and OvLV
4 viruses were 1:200 and 1:50, respectively (not shown).
hese results indicate that independent OvLV 34 and
vLV 28 neutralization epitopes were recognized se-
uentially by lamb C28, supporting the conclusion that a
ariant of OvLV 28 expressing the OvLV 34 epitope ex-
lusively evolved prior to 8 weeks PI. This conclusion
as also supported by studies with virus isolates from
vLV-28-infected lambs A28 and B28 (described below).
eutralization phenotype of virus isolates
rom OvLV-34-infected lambs
Virus isolates A34.1 and B34.1 were obtained from
lveolar macrophages of OvLV-34-infected lambs A34
nd B34 at 20 weeks PI (Woodward et al., 1995). To
etermine the neutralization phenotype of isolates A34.1
nd B34.1, these viruses were evaluated for neutraliza-
ion by 20-week autologous sera from lambs A34 and
34. Serum from lamb A34 neutralized 90% of 102.65
CID50 of virus isolate A34.1, and serum from lamb B34
eutralized 99% of 102.93 TCID50 of isolate B34.1 (Table 4).
The OvLV 34 virus inoculum was also neutralized by
erminal sera from lambs A34 and B34 (Table 2). There-
ore, one explanation for the results in Table 4 is that
solates A34.1 and B34.1 represented reisolations of virus
vLV 34, a possibility suggested previously in studies of
heep infected with visna virus (Lutley et al., 1983; Thor-
ar et al., 1983). However, some caprine arthritis–en-
ephalitis virus (CAEV) isolates are neutralized by coin-
ident goat sera drawn at the time of virus isolation, and
hese isolates are distinguishable from the inoculum
TABLE 3
Development of Lamb C28 Serum Neutralizing Antibodies
to OvLV 28 and 34
Virus
Virus titer (Log10TCID50/0.1 ml)
Control sera
Lamb C28 sera (weeks)
4 8 12 16
34 3.07 6 0.66 3.08 1.89* 1.50* 0.87*
28 3.10 6 0.84 3.16 2.61 1.47* 1.59*
Note. Neutralization assays, viruses, and sera are described in
able 1.irus by neutralizing sera drawn prior to virus isolation eCheevers et al., 1993). Therefore, we examined the pos-
ibility that OvLV isolates A34.1 and B34.1 were antigenic
ariants of virus OvLV 34 by determining the temporal
evelopment of neutralizing antibody responses to pa-
ental OvLV 34 virus and homologous virus isolates A34.1
nd B34.1. Lamb A34 developed neutralizing antibodies
o parental OvLV 34 prior to 4 weeks PI, whereas neu-
ralization of the A34.1 virus isolate obtained from this
amb was detected at 13 to 16 weeks (Table 5). Similarly,
arental virus OvLV 34 was neutralized by 13-week se-
um from lamb B34, whereas neutralization of virus B34.1
solated from this lamb was not detected until 15 weeks
Table 5).
These results defined OvLV isolates A34.1 and B34.1
s antigenic variants based on resistance to early type-
pecific neutralizing antibodies against the OvLV 34 virus
noculum. Thus, these variants may have arisen initially
s neutralization escape mutants and subsequently in-
uced neutralizing antibodies. However, the presence of
erum neutralizing antibodies directed to A34.1 and B34.1
ariants at the time of virus isolation at 20 weeks (Tables
and 5) as well as 4 to 5 weeks prior to virus isolation
Table 5) demonstrated that persistent replication of
hese virus variants in lung macrophages was not attrib-
table to neutralization resistance.
eutralization phenotype of virus isolates from
vLV-28-infected lambs
Viruses A28.1 and B28.1 were isolated from OvLV-28-
nfected lambs A28 and B28 at 20 weeks PI (Woodward
t al., 1995). Initial studies to determine the neutralization
henotype of isolates A28.1 and B28.1 are summarized in
able 4. Terminal sera of lambs A28 and B28 at 20 weeks
id not neutralize homologous virus isolates A28.1 and
28.1 assayed at 101.71 and 101.67 TCID50, respectively.
TABLE 4
Neutralization of Virus Isolates by 20-Week Sera
from OvLV-34- and 28-Infected Lambs
Virusa
Virus titer (Log10TCID50/0.1 ml)
Control sera
Test sera
A34 B34 A28 B28
34.1 2.65 6 0.72 65* (90.0)
34.1 2.93 6 0.63 0.94* (99.0)
28.1 2.50 6 0.48 2.61
1.71 6 0.78 1.75
28.1 2.97 6 0.24 2.83
1.67 6 0.40 1.57
Note. Neutralization assays are described in Table 1.
a Viruses A34.1 and B34.1 were isolated from OvLV-34-infected lambs
34 and B34 at 20 weeks PI, and viruses A28.1 and B28.1 were isolated
rom OvLV-28-infected lambs A28 and B28 at 20 weeks PI (Woodward
t al., 1995).
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385OVINE LENTIVIRUS PHENOTYPESince terminal sera of lambs A28 and B28 also did not
eutralize a comparable titer of 101.56 TCID50 of the OvLV
8 virus inoculum (Table 2), the data in Table 4 did not
ifferentiate virus isolates A28.1 and B28.1 from parental
irus OvLV 28. The data in Table 3 indicated that anti-
enic variation of OvLV 28 in vivo resulted in acquisition
f an OvLV-34-specific neutralization epitope. Therefore,
e determined if OvLV 28 and virus isolates A28.1 and
28.1 derived from OvLV-28-infected lambs could be dis-
inguished by heterologous sera from OvLV-34-infected
ambs A34 and B34. These sera neutralized 82.6 and
1.8% of 102.65 TCID50 of isolate A28.1 as well as 99.0 and
6.3% of 103.08 TCID50 of isolate B28.1 (Table 6). Since
vLV 28 was not neutralized by heterologous sera from
ambs A34 and B34 (Table 2), the data in Table 6 defined
irus isolates A28.1 and B28.1 as antigenic variants of
arental virus OvLV 28. These isolates meet the defini-
ion of OvLV 28 variants that acquired an OvLV 34 neu-
ralization epitope.
DISCUSSION
OvLV 34 and OvLV 28 were initially described as dis-
inct virus strains based on replication kinetics, syncytio-
enesis, and cell lysis in vitro (Lairmore et al., 1987;
oodward et al., 1995). The present study defines these
vLV strains as distinct neutralization serotypes and
lso indicates that recognition of at least one OvLV 28
T
Development of Neutralizing Antibodies
Virus Serum Control sera 4 6 8
4 A34 2.92 6 0.48 2.03* 1.38*
34.1 A34 2.51 6 0.72 2.42 2.49
4 B34 3.06 6 0.81 3.32 3.29 2.75
34.1 B34 3.09 6 0.69 3.24 3.01 3.06
Note. Neutralization assays, viruses, and sera are described in Tab
TABLE 6
Neutralization of Virus Isolates A28.1 and B28.1
by Heterologous Lamb Sera
Virus
Virus titer (Log10TCID50/0.1 ml)
Control sera A34 serum B34 serum
28.1 2.65 6 0.39 1.89* (82.6) 2.10* (71.8)
28.1 3.08 6 0.38 1.06* (99.0) 1.65* (96.3)
Note. Neutralization assays, viruses, and sera are described in
fables 1 and 3.eutralization epitope is influenced by immunogenetic
ifferences between pairs of monozygotic twin lambs.
vLV 34 induced only type-specific neutralizing antibod-
es in lambs A34, B34, and C34 infected with this virus
train, whereas sera from their identical twins A28, B28,
nd C28 infected with OvLV 28 had neutralizing antibod-
es to heterologous OvLV 34. Sera from two OvLV-28-
nfected lambs (A28 and B28) neutralized heterologous
vLV 34 virus exclusively, whereas serum from lamb C28
eutralized OvLV 28 and OvLV 34 viruses. The basis of
eterologous neutralizing antibody responses in OvLV-
8-infected lambs was investigated by evaluation of the
emporal development of serum neutralizing antibodies
o OvLV 28 and OvLV 34 viruses in lamb C28. These
esults, together with evaluation of the neutralization
henotype of virus isolates A28.1 and B28.1, are consis-
ent with the conclusion that a variant of OvLV 28 ac-
uired a neutralization epitope shared with OvLV 34 and
hat immune recognition of this epitope was independent
f genetic differences between lambs. OvLV 28 also
xpressed a type-specific neutralization epitope recog-
ized only by lamb C28, demonstrating that lack of de-
ectable neutralization of OvLV 28 by sera from lambs
28 and B28 was not due to an inherent inability of this
irus to be neutralized. We conclude that OvLV 34 and
vLV 28 are distinct neutralization serotypes and that
ost immunogenetic factors contribute to immune recog-
ition of at least one neutralization epitope expressed on
vLV 28.
Since only one lamb (C28) of three inoculated with
vLV 28 developed a neutralizing antibody response, the
ossibility must be considered that the immune respon-
iveness of this lamb might be related to a higher virus
oad rather than genetic differences from the other two
ambs inoculated with this virus. In a previous semiquan-
itative study of OvLV DNA amplified using LTR primers
rom bronchoalveolar lavage cells or caudal mediastinal
ymph node cells of these lambs at 20 weeks PI, the least
ntense band was consistently found with DNA samples
34 and Virus Isolates A34.1 and B34.1
ter (Log10TCID50/0.1 ml)
Test sera (weeks PI)
10 12 13 14 15 16 20
1.37* 1.28* 1.97*
2.61 1.41* 1.51*
.86 2.45 1.95* 1.97* 2.13* 1.18* 1.53*
.08 2.83 2.87 2.45 2.03* 1.98* 0.00*
d 3.ABLE 5
to OvLV
Virus ti
2
3rom lamb C28 compared with lambs A28 or B28 (de la
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386 CHEEVERS ET AL.oncha-Bermejillo et al., 1995). These results are con-
istent with a lower virus load at necropsy in this lamb
elative to the other two inoculated with OvLV 28. Fur-
hermore, since antibody responses to viral core anti-
ens also may reflect viral load, antibody responses to
ag proteins also were compared in these lambs (de la
oncha-Bermejillo et al., 1995). Briefly, these results
howed the following: (i) p25 Ab was detected at 2 weeks
I in lambs A28 and B28 and at 4 weeks PI in lamb C28.
ii) p16 Ab was detected at 4 weeks PI in lambs A28 and
28 and at 8 weeks PI in lamb C28. (iii) p14 Ab was
etected at 4 weeks PI in lamb B28 and was not detected
y 20 weeks PI in lambs A28 and C28. If antibody re-
ponse is an indirect measure of core antigen load,
hese results suggest that virus load may be somewhat
ower rather than higher in lamb C28 than in lambs A28
nd B28. However, the results probably indicate no sig-
ificant differences between lambs. In any case, induc-
ion of neutralizing antibodies to OvLV 28 in lamb C28 is
ot likely due to more efficient replication of virus in this
amb than in lambs A28 and B28.
Results of this study are relevant to mechanisms of
election and persistent replication of macrophage as-
ociated OvLV variants in vivo, particularly regarding the
ole of neutralizing antibodies. Virus isolates A34.1 and
34.1 were defined as antigenic variants by resistance to
arly OvLV 34 type-specific neutralizing antibodies.
hese data do not formally exclude the possibility that
ariants A34.1 and B34.1 arose initially as neutralization
scape mutants of OvLV 34 parental virus. However,
irus variants A28.1 and B28.1 did not arise as neutral-
zation resistant mutants of parental OvLV 28, since
ambs A28 and B28 did not elicit detectable neutralizing
ntibody responses to either the parental virus or the
ariants. We examined the possibility that neutralizing
ntibodies to OvLV 28 virus developed early and then
ubsided. Sera from lambs A28 and B28 drawn at 4, 8, 12,
nd 16 weeks did not detectably neutralize 103.14 TCID50
f OvLV 28 (not shown), a result which essentially ex-
ludes an early neutralizing antibody response. More-
ver, variants A28.1 and B28.1 acquired a neutralization
pitope shared by OvLV 34 in the absence of OvLV 34
eutralizing antibodies. Similarly, variants of equine in-
ectious anemia virus (EIAV) may arise in the serum of
hronically infected horses in the absence of detectable
eutralizing antibodies against previous isolates (Car-
enter et al., 1987). Thus, it is evident that evolution of
vLV, CAEV, and EIAV variants may be influenced by
election mechanisms other than neutralizing antibod-
es. It was also suggested that HIV variants may be
elected by immune mechanisms other neutralization
esistance or by nonimmune mechanisms (Lukashov et
l., 1995; Domingo et al., 1993).
With regard to the role of neutralizing antibodies in
irus persistence, terminal sera of lambs A34, B34, and
34 neutralized both the OvLV 34 inoculum and homol- Mgous virus isolates A34.1 and B34.1. Virus isolates A34.1
nd B34.1 were also neutralized by sera drawn 4 to 5
eeks prior to virus isolation. Thus, analogous to previ-
us studies with visna virus (Lutley et al., 1983; Thormar
t al., 1983) and CAEV (Cheevers et al., 1993), parental
vLV 34 virus as well as variants A34.1 and B34.1 per-
isted in vivo in the presence of serum neutralizing
ntibodies. These observations suggest that persistent
entivirus replication in tissue macrophages is unaf-
ected by neutralizing antibodies, the presence of which
an be inferred by documentation of antibody producing
lasma cells in inflammed tissues (Wilkerson et al., 1995;
echner et al., 1997). Cell to cell transfer of virus between
acrophages is one way that lentivirus replication can
ypass neutralizing antibodies.
A previous study of the twin lambs evaluated here
ndicated that the severity of OvLV-induced LIP is deter-
ined by host factors and is unrelated to the in vitro
henotype of OvLV 34 and OvLV 28 inocula. Specifically,
amb A34 infected with R/H OvLV 34 and its identical twin
28 infected with S/L OvLV 28 had severe LIP lesions at
0 weeks PI, whereas lambs B34 and C34 infected with
vLV 34 as well as their identical twins B28 and C28
nfected with OvLV 28 had insignificant LIP lesions (de la
oncha-Bermejillo et al., 1995). A subsequent study de-
ermined the in vitro phenotype of virus isolates A34.1,
34.1, A28.1, and B28.1 obtained from bronchoalveolar
acrophages of lambs with severe or insignificant le-
ions. Results of that study confirmed the independence
f in vitro phenotype and disease severity, i.e., S/L OvLV
8 evolved in vivo into R/H phenotypes represented by
solates A28.1 and B28.1 independently of lung lesion
everity (Woodward et al., 1995). The present results
ndicate that host factors contributing to LIP severity
ithin a 20-week time frame do not include neutralizing
ntibody responses, since lamb A34 with severe LIP
esions as well as lambs B34 and C34 with insignificant
esions had homologous neutralizing antibodies to the
vLV 34 inoculum. Moreover, OvLV 28 failed to induce
etectable homologous neutralizing antibodies in lamb
28 with severe LIP as well as lamb B28 without signif-
cant lesions. The present results also did not reveal a
elationship between lung disease and evolution of OvLV
ntigenic variants in vivo. OvLV 34 variants A34.1 and
34.1 emerged in lambs A34 and B34 independently of
IP severity, and OvLV 28 variants were identified from
amb A28 with severe LIP as well as lamb B28 with
nsignificant lesions.
Dependence of lentivirus-induced inflammatory le-
ions on host factors has also been noted in Saanen
oats infected with CAEV. Development of immune-me-
iated arthritis among goats infected with either
AEV-63 (Crawford et al., 1980) or CAEV-Co (Narayan et
l., 1980) correlated positively with early and persistent
ominance of antibody responses (Knowles et al., 1990;
cGuire et al., 1992; Bertoni et al., 1994; Perry et al.,
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387OVINE LENTIVIRUS PHENOTYPES995) but not T lymphocyte proliferative responses (Perry
t al., 1995) to viral envelope glycoproteins. In addition,
oats with arthritis have a dominant population of inter-
eukin-4-positive CAEV gp135 reactive T lymphocytes,
hereas gp135-reactive interferon-g-positive T lympho-
ytes are dominant in long-term asymptomatic goats
Cheevers et al., 1997). Collective results of OvLV and
AEV studies indicate that development of lentivirus-
nduced inflammatory lesions is dependent on host
ather than viral factors. We suggest that the clinical
utcome of infection by strictly macrophage tropic lenti-
iruses represented by OvLV and CAEV is determined by
mmunogenetic criteria that govern activation of distinct
rms of the immune system responding to viral antigenic
eterminants other than neutralization epitopes. This hy-
othesis can be addressed directly by challenge infec-
ion of animals with dominant viral-specific type 1 cell-
ediated immune responses or type 2 humoral immune
esponses induced by vaccination.
MATERIALS AND METHODS
nimals
Monozygotic twin lambs used in this study (Table 1)
ere produced by splitting single embryos recovered
rom Suffolk ewes at the late morula or early blastocyst
tages and transferring them to the uterus of a recipient
we as described previously (de la Concha-Bermejillo et
l., 1995). The animals were maintained in individual
ens in temperature- and air flow-controlled rooms. Sep-
rate rooms were used for groups of lambs inoculated
ith each OvLV strain or medium.
iruses
OvLV 34 was originally isolated from a sheep with LIP
Lairmore et al., 1986). OvLV 28 was isolated from a
heep with LIP and concurrent pulmonary carcinoma
DeMartini et al., 1987). These virus isolates were plaque
urified and characterized phenotypically based on rep-
ication kinetics, syncytiogenesis, and cell lysis in GSM
ultures as described by Querat et al. (1984). Virus OvLV
4 is a lytic or R/H OvLV strain based on rapid replication
inetics, formation of syncytia, and extensive cell lysis,
hereas virus OvLV 28 is a persistent or S/L OvLV strain
ased on relatively slow replication kinetics, minimal
yncytiogenesis, and absence of cell lysis (Lairmore et
l., 1987; Woodward et al., 1995).
Virus isolates A34.1, A28.1, B34.1, and B28.1 were ob-
ained by coculture of GSM cells with bronchoalveolar
avage macrophages obtained from twin lambs inocu-
ated with R/H OvLV 34 or S/L OvLV 28 (de la Concha-
ermejillo et al., 1995; Woodward et al., 1995). Virus
solates A34.1 and B34.1 were obtained from OvLV-34-
nfected lambs A34 and B34. Virus isolates A28.1 and
28.1 were obtained from OvLV-28-infected lambs A28 Ctwin of A34) and B28 (twin of B34). The virus isolates,
hich were subsequently characterized in vitro as R/H
henotypes (Woodward et al., 1995), were plaque puri-
ied three times and amplified in GSM cells for use in
erum neutralization assays.
era
Sera were obtained from twin lambs inoculated previ-
usly with OvLV 34 or OvLV 28 (de la Concha-Bermejillo
t al., 1995). The sera were complement inactivated at
6°C for 1 h prior to use in virus neutralization assays.
irus neutralization assay
Lamb sera were evaluated for neutralization of OvLV
trains OvLV 34, OvLV 28, A34.1, B34.1, A28.1, and B28.1
sing a virus titer reduction assay (McGuire et al., 1988;
heevers et al., 1991, 1993). Virus neutralization in this
ssay is antibody dependent and complement indepen-
ent and requires preincubation of virus with neutralizing
erum (McGuire et al., 1988). Standard mixtures con-
ained 0.1 ml of complement-inactivated serum and 0.1 ml
f virus at a predetermined control infectivity titer. Control
irus titers, expressed as Log10 TCID50/0.1 ml, were de-
ermined by separate infectivity titrations in the presence
f serum from lambs 86-30, 86-32, 86-35, and 90-18 sham
noculated with cell culture medium. Sera that reduced
he virus titer below 3 SD of the mean control titer (P ;
.01) were scored positive for neutralization (McGuire et
l., 1988). Neutralizing antibody titers, expressed as the
ighest positive serum dilution, were determined by in-
ubating 0.1 ml of virus at a constant infectivity titer with
.1 ml of serial dilutions of sera.
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